W.O.M. World of Medicine AG

Second Quarter sales surpass 2006 levels by 18.7%

@@start.t1@@--------------------------------------------------------------------------------   ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for   the content of this announcement. --------------------------------------------------------------------------------@@end@@

balance/Half-year Report

Ludwigsstadt (euro adhoc) - An increase in sales of 18.7% over the second quarter of 2006, and 7.5% growth in mid-year sales to TE16,174: These are the extremely impressive results of the first six months of fiscal year 2007 for listed medical device manufacturer WORLD OF MEDICINE. Earnings before taxes (EBT) from continued operations rose in the first half-year by almost E2.0 million, to TE2,414, when compared with the same period last year. The corresponding pre- tax sales yield equaled 14.9% (same period last year: 3.0%). "The second quarter developed far better than expected," said Peter P. Wiest, CEO of WORLD OF MEDICINE. "In addition to existing business operations, sales of the new generation of pumps contributed to the excellent performance. By the end of June, more than twice as many devices had been sold as in the same period last year."

|                              |HY1/2007                 |HY1/2006                 |Change
|Sales                      |TE16,174                 |TE15,048                 |+ 7.5 %
|EBT                         |TE2,414                  |TE459                      |+TE1,955
|Sales yield            |14.9%                      |3.0%                        |> 100%
|Earnings per share |E0.27                      |E0.03                      |> 100%

Moreover, income not included in the 2007 budget was received in the form of payments from former subsidiary IB Laser AG. WORLD OF MEDICINE is now reviewing the use of these funds for the advancement of development projects scheduled for 2008. "This may place a strain on consolidated net income in the second half-year, as will the corporate tax reform passed by the German Bundesrat. For this reason, the after-tax yield of 15.0% shown at half-year cannot be projected on a linear basis across the year as a whole," states Peter P. Wiest. "However, we see clear indications that the momentum for growth will continue unabated: The volume of orders at the end of June reached its highest level for the year, and is now 57.4% ahead of that same figure at last year's reporting date. Sales development in July was extremely impressive, and production is more than fully utilized."

The Management Board therefore stands behind its projection of a 10% pre-tax sales yield for the year 2007.

The full half-year report is available at www.world-of-medicine.com/wsc/q2-2007-en.pdf

WORLD OF MEDICINE and its technologies are paving the way in Minimally Invasive Surgery - or MIS( for short. This approach includes safe and gentle surgical procedures conducted not through major incisions, but through keyhole or puncture incisions. The Company is the global market leader in a niche of this future market.

Today at 2:00 pm CET, a telephone conference on the quarterly figures is scheduled for analysts, investors and press representatives. To participate, please contact WORLD OF MEDICINE directly.

@@start.t2@@end of announcement                                                 euro adhoc 09.08.2007 08:00:00

ots Originaltext: W.O.M. World of Medicine AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Stefanie Gehrke
Tel.: +49 (0)30 39981 566
E-Mail: stefanie.gehrke@womcorp.com

Branche: Pharmaceuticals
ISIN:      DE0006637390
WKN:        663739
Index:    CDAX, Prime All Share, Technologie All Share
Börsen:  Börse Frankfurt / regulated dealing/prime standard
              Börse Berlin / free trade
              Börse Hamburg / free trade
              Börse Stuttgart / free trade
              Börse Düsseldorf / free trade
              Börse München / free trade

Weitere Meldungen: W.O.M. World of Medicine AG

Das könnte Sie auch interessieren: